Display Settings:

Format

Send to:

Choose Destination
    BMC Dermatol. 2010 Aug 20;10:6.

    A randomised, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children--melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a "suffocation" product.

    Source

    Parasitology Section, School of Chemistry & Molecular Biosciences, and UniQuest Pty, Ltd,, University of Queensland, St Lucia, Queensland, 4072 Australia. s.barker@uq.edu.au

    Abstract

    BACKGROUND:

    There are many different types of pediculicides available OTC in Australia. In this study we compare the efficacy and safety of three topical pediculicides: a pediculicide containing melaleuca oil (tea tree oil) and lavender oil (TTO/LO); a head lice "suffocation" product; and a product containing pyrethrins and piperonyl butoxide (P/PB).

    METHOD:

    This study was a randomised, assessor-blind, comparative, parallel study of 123 subjects with live head lice. The head lice products were applied according to the manufacturer's instructions (the TTO/LO product and the "suffocation" product were applied three times at weekly intervals according to manufacturers instructions (on Day 0, Day 7 and Day 14) and the P/PB product was applied twice according to manufacturers instructions (on Day 0 and Day 7)). The presence or absence of live lice one day following the last treatment was determined.

    RESULTS:

    The percentage of subjects who were louse-free one day after the last treatment with the product containing tea tree oil and lavender oil (41/42; 97.6%) and the head lice "suffocation" product (40/41, 97.6%) was significantly higher compared to the percentage of subjects who were louse-free one day after the last treatment with the product containing pyrethrins and piperonyl butoxide (10/40, 25.0%; adj. p < 0.0001).

    CONCLUSION:

    The high efficacy of the TTO/LO product and the head lice "suffocation" product offers an alternative to the pyrethrins-based product.

    TRIAL REGISTRATION:

    The study was entered into the Australian/New Zealand Clinical Trial Registry, ACTRN12610000179033.

    PMID:
    20727129
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2933647
    Free PMC Article

    Images from this publication.See all images (1) Free text

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk